Arin LogoArin
Back

ACRYLAMIDE

Flagged0 products
CAS
79-06-1
EC
2011737
PubChem CID
6579
Molecular Formula
C3H5NO
Molecular Weight
71.0800 g/mol

A full English write-up is not available yet. Category and regulatory notes above still apply.

Hazards

Function & Use

Not Reported

Regulatory note

  • EU 1223/2009 Annex IIProhibited

Industry GHS notices (PubChem)

These are industry self-reports to ECHA, not our regulatory assessment.

  • H301(94.8%)- Toxic if swallowed
  • H311- Toxic in contact with skin
  • H312(94.2%)- Harmful in contact with skin
  • H315(96.2%)- Causes skin irritation
  • H316- H316
  • H317(96.2%)- May cause an allergic skin reaction
  • H319(96.0%)- Causes serious eye irritation
  • H332(94.6%)- Harmful if inhaled
  • H340(96.2%)- May cause genetic defects
  • H350(96.1%)- May cause cancer
  • H360- May damage fertility or the unborn child
  • H361(94.1%)- Suspected of damaging fertility or the unborn child
  • H370- Causes damage to organs
  • H372(94.8%)- Causes damage to organs through prolonged or repeated exposure
  • H402- Harmful to aquatic life
PubChem CID 6579
The verdict isn’t ours: below is what ToxValDB (EPA Toxicity Value Database), SCCS (EU Scientific Committee on Consumer Safety), EPA ToxCast (high-throughput in vitro screening), IARC (International Agency for Research on Cancer) said, verbatim.

What The Sources Say

SCCS (EU Scientific Committee on Consumer Safety)4
Safety assessment

EU 1223/2009 Annex II — SCCS opinion: Mutagenic or Toxic to Reproduction according to the Chemicals Directive 67/548/EEC

Safety assessment

EU 1223/2009 Annex II — SCCS opinion: Mutagenic or Toxic to Reproduction according to the Chemicals Directive 67/548/EECC

Safety assessment

EU 1223/2009 Annex II — SCCS opinion: Opinion concerning Chemical Ingredients in Cosmetic Products classified as Carcinogenic

+1 more records.

IARC (International Agency for Research on Cancer)1
Hazard claimView source →

IARC Group 2A - Probably carcinogenic to humans. Limited evidence in humans, sufficient evidence in experimental animals. (Monograph volume: 60, Sup 7). Caveat: IARC classifies HAZARD, not RISK - it says 'can cause cancer under some conditions', not 'causes cancer at cosmetic use levels'. Route and dose must be assessed separately. Data is a 01/2021 snapshot.

ToxValDB (EPA Toxicity Value Database)23
Hazard claimView source →

EPA ToxValDB skin/eye data — endpoint: Skin Irritation, classification: Skin irritation - category 2. Caveat: this is an aggregated record; dose, species and route of exposure must be considered together.

Hazard claimView source →

EPA ToxValDB skin/eye data — endpoint: Skin Sensitization, classification: Skin sensitisation - category 1. Caveat: this is an aggregated record; dose, species and route of exposure must be considered together.

Hazard claimView source →

EPA ToxValDB skin/eye data — endpoint: Eye Irritation, classification: Serious eye damage/eye irritation - Category 2. Caveat: this is an aggregated record; dose, species and route of exposure must be considered together.

Hazard claimView source →

EPA ToxValDB skin/eye data — endpoint: Skin Irritation, classification: Not classified. Caveat: this is an aggregated record; dose, species and route of exposure must be considered together.

Hazard claimView source →

EPA ToxValDB skin/eye data — endpoint: Skin Irritation, classification: Category 6.3B (Category 3). Caveat: this is an aggregated record; dose, species and route of exposure must be considered together.

+18 more records.

EPA ToxCast (high-throughput in vitro screening)1
Safety assessmentView source →

EPA ToxCast ER model: NO estrogen receptor activity found (AUC agonist=0, antagonist=0). Tested in 18 in vitro assays. Caveat: this is an in vitro screening model with no dose or exposure context; it does NOT mean an effect occurs in humans at cosmetic use levels.

Scientific References

  • EPA CompTox Chemicals Dashboard - DSSTox identifiers mapped to CAS (2021r1)US EPA, Center for Computational Toxicology and Exposure
  • EPA ToxCast/Tox21 - endocrine pathway screening (ER CERAPP, AR)US EPA, Center for Computational Toxicology and Exposure
  • EU CosIng - Cosmetic Ingredient Database full exportEuropean Commission, DG GROW
  • IARC Monographs - Acrylamide (Group 2A - Probably carcinogenic to humans)IARC — WHO Uluslararası Kanser Araştırmaları Ajansı
  • Mutagenic or Toxic to Reproduction according to the Chemicals Directive 67/548/EECSCCS — Scientific Committee on Consumer Safety
  • Mutagenic or Toxic to Reproduction according to the Chemicals Directive 67/548/EECCSCCS — Scientific Committee on Consumer Safety
  • Opinion concerning Chemical Ingredients in Cosmetic Products classified as CarcinogenicSCCS — Scientific Committee on Consumer Safety
  • PubChem - CID-Synonym-filtered bulk + PUG REST propertiesNCBI / National Library of Medicine
  • ToxCast ER model - Acrylamide (DTXSID5020027)US EPA — ToxCast / CompTox
  • ToxValDB - cancerUS EPA — ToxValDB v97
  • ToxValDB - genotoxicityUS EPA — ToxValDB v97
  • ToxValDB - skin/eyeUS EPA — ToxValDB v97